Abstract: A novel gRNA-ligand binding complex is provided. This complex may be used to bring Type V Cas proteins and additional effectors to DNA for base editing. The design of the systems allows for the production of efficient modular components that provide flexibility when editing DNA.

Abstract: A method for preparing an aqueous dispersion of metal oxide particles is disclosed. The method comprises the step of performing phase transfer of a plurality of metal oxide particles capped with hydrophobic ligands on a surface there of by contacting the metal oxide particles with a combination of tertiary amine and water to form a biphasic mixture, and agitating said biphasic mixture to produce an aqueous dispersion of metal oxide particles capped with hydrophobic ligands and tertiary amine ligands on the surface thereof.

Abstract: A multimodal PET (positron emission tomography)/MRI (magnetic resonance imaging) contrast agent, a process of synthesizing said PET/MRI contrast agent, and a pharmaceutical formulation comprising said PET/MRI contrast agent are disclosed. The PET/MRI contrast agent comprises a magnetic signal generating core, and a coating portion formed at least partially over a surface of said magnetic signal generating core, wherein the coating portion comprises a plurality of layers, including an inner layer having a functionalized surface, and an outer layer in the form of a radionuclide electrolessly plated layer formed on said functionalized surface.

Abstract: A method of purifying a plurality of metal oxide particles produced from a synthesis process comprising the step of washing a plurality of metal oxide particles in a first solvent composition comprising of at least one aliphatic ether, and at least one flocculant. In one embodiment, the plurality of metal oxide particles are iron oxide particles produced from a thermal decomposition synthesis process between an iron-oleate complex and oleic acid in 1-octadecene, wherein the first solvent composition comprises a 1:1 (vol/vol) ratio of an aliphatic ether in the form of diethyl ether and a flocculant in the form of methanol. The washed iron oxide particles are further washed in a second solvent composition comprising a 1:1 (vol/vol) ratio of hexane and ethanol, and then finally dispersed in hexane. The resulting iron oxide particles find use as a contrast agent for magnetic resonance imaging (MRI) or as magnetic particles in magnetic separation, magnetism-directed targeting or magnetism-induced heating.

Abstract: A method for preparing an aqueous dispersion of metal oxide particles is disclosed. The method comprises the step of performing phase transfer of a plurality of metal oxide particles capped with hydrophobic ligands on a surface there of by contacting the metal oxide particles with a combination of tertiary amine and water to form a biphasic mixture, and agitating said biphasic mixture to produce an aqueous dispersion of metal oxide particles capped with hydrophobic ligands and tertiary amine ligands on the surface thereof.

Abstract: A multimodal PET (positron emission tomography)/MRI (magnetic resonance imaging) contrast agent, a process of synthesizing said PET/MRI contrast agent, and a pharmaceutical formulation comprising said PET/MRI contrast agent are disclosed. The PET/MRI contrast agent comprises a magnetic signal generating core, and a coating portion formed at least partially over a surface of said magnetic signal generating core, wherein the coating portion comprises a plurality of layers, including an inner layer having a functionalized surface, and an outer layer in the form of a radionuclide electrolessly plated layer formed on said functionalized surface.

Abstract: A method of purifying a plurality of metal oxide particles produced from a synthesis process is disclosed. The method comprises the step of washing a plurality of metal oxide particles in a first solvent composition comprising of at least one aliphatic ether, and at least one flocculant. In one embodiment, the plurality of metal oxide particles are iron oxide particles produced from a thermal decomposition synthesis process between an iron-oleate complex and oleic acid in 1-octadecene, wherein the first solvent composition comprises a 1:1 (vol/vol) ratio of an aliphatic ether in the form of diethyl ether and a flocculant in the form of methanol. The washed iron oxide particles are further washed in a second solvent composition comprising a 1:1 (vol/vol) ratio of hexane and ethanol, and then finally dispersed in hexane.

Abstract: A speakerless headset apparatus has a first earpiece and a second earpiece, each earpiece configured to rest on, or over, the ear of a user. Each earpiece is coupled to a respective sound conduit (i.e., the first earpiece is coupled to a first sound conduit). Each conduit is removably coupleable to one or more speaker housings, the speaker housing having one or more speakers for outputting audio received from an audio device. The one or more speakers electrically coupled to an audio output device.

Abstract: A method and system for assessing road conditions is provided. The method includes determining a road hazard condition for a road segment that may include a precipitation type, a pavement condition, and a visibility level. The precipitation type may be determined using radar data, satellite cloud classification data, weather station air temperature data, wiper status, mobile air data, speed ratio, or headlight status. The pavement condition may be determined using pavement temperature, precipitation type, automatic brake system status, traction status or a stability control observation, and a yaw rate. The visibility level may be determined using wind speed, relative humidity, percentage of fog lights on, percentage of high beams on, speed ratio, station visibility, station-reported visibility type, wildfire existence, wind direction, a dust existence indicator.

Abstract: A method and system for assessing road conditions is provided. The method includes determining a road hazard condition for a road segment that may include a precipitation type, a pavement condition, and a visibility level. The precipitation type may be determined using radar data, satellite cloud classification data, weather station air temperature data, wiper status, mobile air data, speed ratio, or headlight status. The pavement condition may be determined using pavement temperature, precipitation type, automatic brake system status, traction status or a stability control observation, and a yaw rate. The visibility level may be determined using wind speed, relative humidity, percentage of fog lights on, percentage of high beams on, speed ratio, station visibility, station-reported visibility type, wildfire existence, wind direction, a dust existence indicator.

Abstract: The present invention relates to immunogenic peptides and their various applications. In particular the invention relates to immunogenic peptides derived from the PASD1 protein and their use in therapeutic, diagnostic and prognostic methods.

Abstract: The present invention relates to immunogenic peptides and their various applications. In particular the invention relates to immunogenic peptides derived from the PASD1 protein and their use in therapeutic, diagnostic and prognostic methods.

Abstract: The present invention relates to immunogenic peptides and their various applications. In particular the invention relates to immunogenic peptides derived from the PASD1 protein and their use in therapeutic, diagnostic and prognostic methods.